Cameco Corporation $CCJ Position Trimmed by Klein Pavlis & Peasley Financial Inc.

Klein Pavlis & Peasley Financial Inc. decreased its stake in Cameco Corporation (NYSE:CCJFree Report) (TSE:CCO) by 16.2% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 89,762 shares of the basic materials company’s stock after selling 17,415 shares during the quarter. Cameco makes up 4.6% of Klein Pavlis & Peasley Financial Inc.’s portfolio, making the stock its 2nd biggest holding. Klein Pavlis & Peasley Financial Inc.’s holdings in Cameco were worth $7,527,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also recently made changes to their positions in CCJ. Financial Consulate Inc. bought a new position in shares of Cameco during the 3rd quarter valued at approximately $25,000. Trust Co. of Vermont lifted its holdings in Cameco by 1,029.4% during the second quarter. Trust Co. of Vermont now owns 384 shares of the basic materials company’s stock valued at $29,000 after purchasing an additional 350 shares in the last quarter. Armstrong Advisory Group Inc. boosted its position in shares of Cameco by 110.3% in the third quarter. Armstrong Advisory Group Inc. now owns 347 shares of the basic materials company’s stock worth $29,000 after purchasing an additional 182 shares during the period. Hilltop National Bank purchased a new stake in shares of Cameco in the second quarter worth $30,000. Finally, Atticus Wealth Management LLC bought a new stake in shares of Cameco during the 2nd quarter valued at $34,000. 70.21% of the stock is owned by hedge funds and other institutional investors.

Cameco Stock Up 3.2%

CCJ opened at $116.50 on Friday. The company has a market capitalization of $50.73 billion, a PE ratio of 135.47 and a beta of 1.01. The firm has a 50-day simple moving average of $93.29 and a two-hundred day simple moving average of $85.60. The company has a quick ratio of 1.85, a current ratio of 2.99 and a debt-to-equity ratio of 0.15. Cameco Corporation has a 52 week low of $35.00 and a 52 week high of $118.54.

Cameco (NYSE:CCJGet Free Report) (TSE:CCO) last posted its earnings results on Wednesday, November 5th. The basic materials company reported $0.05 EPS for the quarter, missing analysts’ consensus estimates of $0.22 by ($0.17). Cameco had a return on equity of 8.58% and a net margin of 15.24%.The firm had revenue of $313.74 million during the quarter, compared to analysts’ expectations of $531.72 million. During the same quarter in the prior year, the firm posted ($0.01) earnings per share. Cameco’s quarterly revenue was down 14.7% on a year-over-year basis. Analysts forecast that Cameco Corporation will post 1.27 earnings per share for the current fiscal year.

Cameco Increases Dividend

The company also recently announced an annual dividend, which was paid on Tuesday, December 16th. Stockholders of record on Monday, December 1st were given a dividend of $0.24 per share. The ex-dividend date was Monday, December 1st. This represents a dividend yield of 27.0%. This is an increase from Cameco’s previous annual dividend of $0.12. Cameco’s dividend payout ratio is currently 19.77%.

Cameco News Summary

Here are the key news stories impacting Cameco this week:

  • Positive Sentiment: Zacks upgraded Cameco from Hold to Strong Buy and added CCJ to its Zacks Rank #1 (Strong Buy) and momentum lists, signaling rising analyst optimism about earnings and near-term upside potential. Read More.
  • Positive Sentiment: Bank of America included Cameco on a short list of three metals/mining stocks to own in 2026, highlighting uranium’s role in the global nuclear buildout and Cameco’s contract-heavy business model that provides revenue visibility. Read More.
  • Positive Sentiment: Unusually large call-option activity: about 384,705 calls were bought on Thursday (~1,490% above normal daily call volume), a flows signal consistent with speculative bullish positioning that can amplify upward price moves. Read More.
  • Positive Sentiment: Multiple Zacks items explain why CCJ joined lists of new Strong Buy and momentum picks, reinforcing the narrative that upgrades and positive screen-based coverage are driving investor demand. Read More.
  • Neutral Sentiment: A sector comparison article highlights Cameco’s strong year-to-date performance vs. oil/energy peers and another uranium player (UROY), which provides context but is not a direct catalyst. Read More.
  • Neutral Sentiment: A Zacks piece on Wall Street optimism reviews analyst sentiment and explains how brokerage ratings can affect price; useful framing but not a new catalyst. Read More.
  • Negative Sentiment: Reported insider selling: Rep. Gilbert Ray Cisneros, Jr. reportedly unloaded Cameco shares, which can be viewed negatively by some investors as a signal of reduced insider conviction (though one sale alone is often ambiguous). Read More.

Analyst Ratings Changes

Several brokerages recently weighed in on CCJ. The Goldman Sachs Group upped their target price on shares of Cameco from $95.00 to $109.00 and gave the stock a “buy” rating in a report on Wednesday, October 29th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Cameco in a research note on Monday, December 29th. National Bankshares reissued an “outperform” rating on shares of Cameco in a research note on Thursday, November 6th. President Capital upgraded Cameco from a “neutral” rating to a “buy” rating in a research note on Monday, September 22nd. Finally, UBS Group initiated coverage on shares of Cameco in a report on Monday, November 10th. They set a “neutral” rating and a $140.00 price objective for the company. Two investment analysts have rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and two have given a Hold rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Buy” and an average target price of $121.68.

Get Our Latest Research Report on CCJ

Cameco Profile

(Free Report)

Cameco Corporation (NYSE: CCJ) is a leading producer of uranium and a supplier to the global nuclear power industry. Headquartered in Saskatoon, Saskatchewan, Canada, the company is engaged in the exploration, mining, milling and sale of uranium concentrate, commonly known as yellowcake, which is used as fuel for nuclear reactors. Cameco also participates in services and activities that support the front end of the nuclear fuel cycle, including processing and marketing of uranium to utilities under long‑term and spot contracts.

The company’s operations have historically centered in Canada and the United States, where it operates and develops uranium mining and processing properties.

Further Reading

Want to see what other hedge funds are holding CCJ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cameco Corporation (NYSE:CCJFree Report) (TSE:CCO).

Institutional Ownership by Quarter for Cameco (NYSE:CCJ)

Receive News & Ratings for Cameco Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cameco and related companies with MarketBeat.com's FREE daily email newsletter.